284 related articles for article (PubMed ID: 33583755)
1. Atrial fibrillation in patients with COVID-19. Usefulness of the CHA
Uribarri A; Núñez-Gil IJ; Aparisi Á; Arroyo-Espliguero R; Maroun Eid C; Romero R; Becerra-Muñoz VM; Feltes G; Molina M; García-Aguado M; Cerrato E; Capel-Astrua T; Alfonso-Rodríguez E; Castro-Mejía AF; Raposeiras-Roubín S; Espejo C; Pérez-Solé N; Bardají A; Marín F; Fabregat-Andrés Ó; D'ascenzo F; Santoro F; Akin I; Estrada V; Fernández-Ortiz A; Macaya C;
Rev Esp Cardiol (Engl Ed); 2021 Jul; 74(7):608-615. PubMed ID: 33583755
[TBL] [Abstract][Full Text] [Related]
2. [Atrial fibrillation in patients with COVID-19. Usefulness of the CHA
Uribarri A; Núñez-Gil IJ; Aparisi Á; Arroyo-Espliguero R; Maroun Eid C; Romero R; Becerra-Muñoz VM; Feltes G; Molina M; García-Aguado M; Cerrato E; Capel-Astrua T; Alfonso-Rodríguez E; Castro-Mejía AF; Raposeiras-Roubín S; Espejo C; Pérez-Solé N; Bardají A; Marín F; Fabregat-Andrés Ó; D'ascenzo F; Santoro F; Akin I; Estrada V; Fernández-Ortiz A; Macaya C;
Rev Esp Cardiol; 2021 Jul; 74(7):608-615. PubMed ID: 33678938
[TBL] [Abstract][Full Text] [Related]
3. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
[TBL] [Abstract][Full Text] [Related]
4. Relationship among atrial fibrillation, the CHA
Shi B; Liu D; Wang Q; Geng X; Hou Q; Gu G; Xie R; Cui W
BMC Cardiovasc Disord; 2021 Oct; 21(1):474. PubMed ID: 34600490
[TBL] [Abstract][Full Text] [Related]
5. Risk Stratification for Ischemic Cerebrovascular Events and Mortality among Intracerebral Hemorrhage Patients with and without Atrial Fibrillation: A Nationwide Cohort Study.
Nielsen PB; Overvad TF; Andersen SD; Larsen TB; Skjøth F; Søgaard M; Lip GYH
Cerebrovasc Dis; 2019; 48(3-6):236-243. PubMed ID: 31846970
[TBL] [Abstract][Full Text] [Related]
6. The Value of the CHADS
Yang HJ; Wang GJ; Shuai W; Shen CJ; Kong B; Huang H
J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104143. PubMed ID: 31477449
[TBL] [Abstract][Full Text] [Related]
7. The ATRIA score is superior to the m-CHA2DS2-Vasc score in predicting in-hospital mortality in COVID-19.
Abacioglu OO; Yildirim A
Rev Assoc Med Bras (1992); 2021 Mar; 67(3):443-448. PubMed ID: 34468612
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation.
Jover E; Roldán V; Gallego P; Hernández-Romero D; Valdés M; Vicente V; Lip GY; Marín F
Rev Esp Cardiol (Engl Ed); 2012 Jul; 65(7):627-33. PubMed ID: 22609214
[TBL] [Abstract][Full Text] [Related]
9. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
[TBL] [Abstract][Full Text] [Related]
10. Comparison of CHA
Hu WS; Lin CL
Atherosclerosis; 2017 Nov; 266():205-211. PubMed ID: 29049919
[TBL] [Abstract][Full Text] [Related]
11. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
12. Prestroke CHA
Acciarresi M; Paciaroni M; Agnelli G; Falocci N; Caso V; Becattini C; Marcheselli S; Rueckert C; Pezzini A; Morotti A; Costa P; Padovani A; Csiba L; Szabó L; Sohn SI; Tassinari T; Abdul-Rahim AH; Michel P; Cordier M; Vanacker P; Remillard S; Alberti A; Venti M; D'Amore C; Scoditti U; Denti L; Orlandi G; Chiti A; Gialdini G; Bovi P; Carletti M; Rigatelli A; Putaala J; Tatlisumak T; Masotti L; Lorenzini G; Tassi R; Guideri F; Martini G; Tsivgoulis G; Vadikolias K; Liantinioti C; Corea F; Del Sette M; Ageno W; De Lodovici ML; Bono G; Baldi A; D'Anna S; Sacco S; Carolei A; Tiseo C; Imberti D; Zabzuni D; Doronin B; Volodina V; Consoli D; Galati F; Pieroni A; Toni D; Monaco S; Baronello MM; Barlinn K; Pallesen LP; Kepplinger J; Bodechtel U; Gerber J; Deleu D; Melikyan G; Ibrahim F; Akhtar N; Mosconi MG; Lees KR
J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1363-1368. PubMed ID: 28236595
[TBL] [Abstract][Full Text] [Related]
13. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
[TBL] [Abstract][Full Text] [Related]
14. Competitive interaction between chronic obstructive pulmonary disease and CHA
Perticone M; Sciacqua A; Tripepi G; Miceli S; Corrao S; Sesti G; Perticone F
Int J Cardiol; 2018 Mar; 255():74-79. PubMed ID: 29174184
[TBL] [Abstract][Full Text] [Related]
15. CHA
Harb SC; Wang TKM; Nemer D; Wu Y; Cho L; Menon V; Wazni O; Cremer PC; Jaber W
Open Heart; 2021 Nov; 8(2):. PubMed ID: 34815301
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
[TBL] [Abstract][Full Text] [Related]
17. Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation.
Fox KAA; Lucas JE; Pieper KS; Bassand JP; Camm AJ; Fitzmaurice DA; Goldhaber SZ; Goto S; Haas S; Hacke W; Kayani G; Oto A; Mantovani LG; Misselwitz F; Piccini JP; Turpie AGG; Verheugt FWA; Kakkar AK;
BMJ Open; 2017 Dec; 7(12):e017157. PubMed ID: 29273652
[TBL] [Abstract][Full Text] [Related]
18. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study.
Lip GYH; Jensen M; Melgaard L; Skjøth F; Nielsen PB; Larsen TB
Europace; 2019 Jan; 21(1):33-40. PubMed ID: 29986001
[TBL] [Abstract][Full Text] [Related]
19. CHADS₂, CHA₂S₂DS₂-VASc, and long-term stroke outcome in patients without atrial fibrillation.
Ntaios G; Lip GY; Makaritsis K; Papavasileiou V; Vemmou A; Koroboki E; Savvari P; Manios E; Milionis H; Vemmos K
Neurology; 2013 Mar; 80(11):1009-17. PubMed ID: 23408865
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for predicting incident atrial fibrillation in heart failure with preserved ejection fraction patients.
Wu Y; Xie Z; Liang W; Xue R; Wu Z; Wu D; He J; Zhu W; Liu C
ESC Heart Fail; 2021 Apr; 8(2):1369-1377. PubMed ID: 33506643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
